AI can understand animal cancer, improving human treatment possibilities
Understanding cancer isn't just about studying humans - it's a problem that spans across many species.
In a groundbreaking study led by The Institute of...
The stroke-blood pressure paradox: a closer look
Strokes are serious and life-threatening medical emergencies that occur when the blood supply to the brain is cut off, causing brain cells to die.
Astonishingly,...
Scientists find an important cause of fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, frequently affecting individuals who consume little or no alcohol, particularly those of...
Scientists find a key to early detection of pancreatic cancer
A recent study led by the Johns Hopkins Kimmel Cancer Center has found that surveillance programs for high-risk individuals can detect pancreatic cancers early.
This...
Diabetes and tooth loss are linked to faster cognitive decline
A recent study indicates that older adults suffering from diabetes and complete tooth loss experience more severe cognitive decline and at a faster rate...
Combating type 2 diabetes: the dual role of genetics and diet
A novel study has established that both genetic risk factors and diet quality play independent roles in determining the risk of developing type 2...
Research shows a new cause of heart rhythm disorders
A recent study by scientists from The Ohio State University offers new hope for people suffering from certain heart rhythm disorders.
The researchers focused on...
High blood pressure: a silent threat to our brains
High blood pressure, or hypertension, is often compared to a silent thief. It's a medical condition where the force of blood against your artery...
Diabetes drugs and dementia risk: a new hope
A research collaboration, including the University of Arizona, has found that an older class of type 2 diabetes drugs, known as glitazones or thiazolidinediones...
A major breakthrough: tailoring prostate cancer treatment with AI
A new study brings hope for men suffering from a common type of prostate cancer, the intermediate-risk type.
ArteraAI, a company that develops cancer tests...